Treatment of rheumatoid arthritis. A short-term cross-over trial of benorylate (Benoral) tablets

Geza P. Balint, Myron E. Mavrikakis, Luis A. Hernandez, Marion M. MacLeod

Research output: Contribution to journalArticle


A short-term, cross-over therapeutic trial of benorylate (Benoral) tablets was carried out in 18 patients with rheumatoid arthritis. At a dosage of 6 g per day benorylate was shown to be equipotent with 75 mg per day of indomethacin and superior to a placebo in the majority of parameters of assessment.

Original languageEnglish
Pages (from-to)165-168
Number of pages4
JournalClinical Trials Journal
Issue number6
Publication statusPublished - Dec 1 1979



  • Musculoskeletal diseases C5
  • benorylate
  • indomethacin
  • rheumatoid arthritis

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this